[Pharmacologic characteristics and clinical activity of human rituximab anti-CD20 monoclonal antibody]

Ann Ital Med Int. 2003 Jul-Sep;18(3):182-7.
[Article in Italian]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab